PT  - JOURNAL ARTICLE
AU  - MARCO PELLICCIARO
AU  - MARCO MATERAZZO
AU  - CHIARA BUONOMO
AU  - GIANLUCA VANNI
TI  - Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients With Locally Advanced Breast Cancer and Partial Response After Neoadjuvant Chemotherapy
AID  - 10.21873/invivo.12529
DP  - 2021 Jul 01
TA  - In Vivo
PG  - 2489--2494
VI  - 35
IP  - 4
4099  - http://iv.iiarjournals.org/content/35/4/2489.short
4100  - http://iv.iiarjournals.org/content/35/4/2489.full
SO  - In Vivo2021 Jul 01; 35
AB  - Background/Aim: Axillary reverse mapping (ARM) aims to identify and preserve arm drainage in order to prevent lymphedema following axillary lymph node dissection. Oncological-safety and feasibility are still debated, especially in patients with locally-advanced breast cancer (LABC). We report the first case of the AXMAP 1.0 study performed in our Institution. Patients and Methods: A 52-year-old patient with a triple-negative LABC and partial response to neoadjuvant chemotherapy underwent axillary lymph-node dissection using fluorescence ARM. Results: Two lymph-nodes draining the ipsilateral upper arm were identified and were not preserved due to suspicion of malignancy. Pathological examination confirmed the presence of malignancy in both lymph nodes. Conclusion: Further studies should be designed in order to validate the oncological safety of this technique, especially in patients with LABC requiring neoadjuvant chemotherapy.